Delivery Order SPE2DB22D1041-SPE2DB25FUCF5
- Not listed
- The Defense Logistics Agency awarded a $1,208.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 31, 2025, with a ceiling value of $1,748.61 and an ultimate completion date of August 1, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $3,165.39 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for Tobradex Eye Ointment (3.5gm) with a ceiling value of $1,639.13 under a firm fixed-price delivery order contract. This award is a non-set-aside, competitively awarded contract executed through the company's existing Indefinite Delivery Contract with DLA. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a $1,857.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 5, 2025, with a completion date of September 8, 2025. This non-set-aside contract represents a small-value pharmaceutical delivery under the company's broader relationship with DLA Medical Supply Chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,082.34 to AmerisourceBergen Drug Corp for Tobradex Eye Ointment 3.5GM on September 23, 2025. This competitive award uses firm fixed pricing with no set-aside designation and is set for completion by September 24, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,850.39 to supply Tobradex eye ointment (3.5 grams) under a firm fixed price contract. The award was made on July 3, 2025, with an ultimate completion date of July 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded to AmerisourceBergen, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,581.72 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price delivery order was not set-aside and was competitively awarded. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order leverages...
- The Defense Logistics Agency awarded a delivery order valued at $1,434.64 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Tobradex is a combination ophthalmic medication commonly used for treating eye inflammation and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,130 to Amerisourcebergen Drug Corporation for Tobradex eye ointment. The order is to be fulfilled by Amerisourcebergen's corporate office in Conshohocken, Pennsylvania and completed within one day, between June 21 and June 22, 2023. As a major distributor of pharmaceuticals and medical supplies to the U.S. Department of Defense, Amerisourcebergen will deliver the requested Tobradex eye ointment in...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUCF5Delivery Order
The Defense Logistics Agency awarded a $12,048.20 delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 22, 2025, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor and healthcare solutions provider. This award reflects AmerisourceBergen's established role as a critical pharmaceutical supplier to federal military and veteran healthcare systems. The Tobradex ophthalmic ointment delivery supports the Defense Health Agency and other government healthcare programs through AmerisourceBergen's comprehensive pharmaceutical prime vendor contract, which enables the distribution of a broad range of medications, vaccines, and medical supplies globally to military healthcare operations. No set-aside designation was used for this procurement, indicating the award resulted from open competition among qualified vendors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 9/22/25 |